All In MedTech

Device Trial Radar · NCT06367621

Retrospective Study of iStatis Syphilis Ab Test (POC)

Retrospective Evaluation of Diagnostic Specificity and Sensitivity for iStatis Syphilis Ab Test at the Point-Of-Care Sites

Last checked: Nov 20, 2026Latest source record: Aug 12, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

1,500

Actual

Start

Nov 15, 2023

Primary completion

Apr 15, 2024

Study completion Jul 11, 2024

Sponsor

Lead sponsor
bioLytical LaboratoriesNot on our public-company list
Sponsor type
Industry
First posted
Apr 16, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 15 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this retrospective clinical trial is to establish the clinical performance of the iStatis Syphilis AbTest. The data will be used to demonstrate the product is safe and effective for its intended use. The data obtained will be used in the application for CE certification under In Vitro Diagnostic Medical Device Regulation (IVDR) and World Health Organization (WHO) prequalification.

Conditions

  • Syphilis
  • Syphilis Infection

Interventions

  • iStatis Syphilis Antibody TestDevice

    1500 stored samples (plasma/serum) will be tested in a routine testing environment using the iStatis Syphilis Antibody Test diagnostic device. Results of tests will not be used for patient management decisions (observaltional).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Sensitivity and specificity of the iStatis Syphilis Ab TestTime frame: 8 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Epicentre Health Research

    Hillcrest, KwaZulu-Natal, South Africa

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.